CeriBell, Inc. (CBLL) Stock

CeriBell, Inc. (CBLL) is a Healthcare stock trading at $18.05 (as of 2026-06-18), with a market capitalization of $700.04M and a trailing P/E of -11.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Valuation — source: SEC EDGAR (first-party)
Price	$18.05
Market Cap	$700.04M
P/E Ratio	-11.4
EV / EBITDA	-10.3
Price / Book	4.98
Price / Sales	7.37
DCF Value (model)	$-17.73
DCF Upside vs Price	-198.3%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$89.06M
Net Margin	-60.0%
Return on Equity	-42.9%
Current Ratio	10.44
Revenue Growth (YoY)	36.1%
EPS Growth (YoY)	-56.9%
FCF Growth (YoY)	14.3%

Financial Health — source: SEC EDGAR
Altman Z-Score	8.99 (safe)

Valuation vs Sector & Industry
Stock P/E	-11.4
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-154.4%
vs Industry	-135.9%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	FMR LLC ($88.91M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Xingjuan Chao
Employees	281
Country	US
IPO Date	2024-10-11

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.